These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-004885-18 Evaluation of febrile event during emopoietic progenitor cells aferesi post chemotherapy treatment in patients affected by multiple myeloma. not-yet-due
Completed, but no date Terminated 2006-002483-26 Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. bad-data
Completed, but no date 2007-000747-10 PHASE II STUDY OF BAY 43-9006 AND INFUSIONAL 5-FLUOROURACIL IN ADVANCED HEPATOCELLULAR CARCINOMA bad-data
Completed, but no date Terminated 2007-001318-18 PHASE II STUDY OF BAY 43-9006, DOCETAXEL AND PREDNISONE IN METASTATIC PROSTATE CANCER bad-data
Ongoing 2007-003831-21 PHARMACOKINETIC PERSPECTIVE STUDY IN COLORECTAL CANCER PATIENTS AND CANDIDATE FOR FLUOROPYRIMIDINE THERAPY: 5-FLUORO TEST not-yet-due
Completed, but no date 2007-003867-36 PILOT STUDY OF PHARMACOGENETICS, CLINICAL EFFICACY AND TOLERABILITY OF CLOZAPINE IN PATIENTS AFFECTED BY SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDERS AND BIPOLAR DISORDERS WITH PSYCHOTIC FEATURES bad-data
Completed, but no date 2007-004165-17 Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. bad-data
Completed, but no date 2007-004267-22 Pharmacogenetic evaluation of oxicodone in patients. bad-data
Completed, but no date 2007-004304-12 Pilot study, randomised, open-label, monocentre, case vs control study to assess the effect of topically and parenterally Heparin administration treatment in superficial and deep second grade burns... bad-data
Ongoing 2007-004487-53 Pilot study of association of VEGF polymorphisms with clinical efficacy and tolerability of therapy in patients affected by exudative (neovascular) age-related macular degeneration. not-yet-due
Completed, but no date 2007-005274-31 Efficacy assessment of tetracycline in patients with progressive external ophthalmoplegia. bad-data
Completed, but no date 2007-005568-28 Safety study of rosiglitazone in patients with acromegaly and assessment of biochemical parameters of disease's activity. bad-data
Completed, but no date 2007-006035-32 Assessment of endothelial function and vasal response in patients with Systemic Sclerosis and Hypercholesterolemia, before and after simvastatin treatment. bad-data
Completed, but no date 2007-006082-32 Female steroid hormones and protection from cardiovascular risk: staminal endothelial progenitor cells and menopause. bad-data
Ongoing 2008-000370-20 Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. not-yet-due
Completed, but no date 2008-001869-29 Mechanism of action and metabolic effects of exenatide in obesity bad-data
Ongoing 2008-003803-30 Effects of the treatment with metformin and/or sitagliptin on β- cell function and insulin resistance in women with prior gestational diabetes. not-yet-due
Ongoing 2008-004628-21 A multicenter phase III randomized study of 153Sm-EDTMP and Docetaxel + Prednisone versus Docetaxel + Prednisone in Taxane-naive patients with metastatic hormone-refractory prostate cancer. not-yet-due
Ongoing 2008-005006-39 Study on the vascular effects of ACE-I + CA-antagonist (Enalapril + Lercanidipine) versus ACE-I + diuretic (Enalapril + hydrochlorothiazidE) combinations in hypertensive patients with metabolic syndro... not-yet-due
Completed, but no date 2008-005042-23 Phase II clinic trial for the reduction of time of hematopoietic stem cell engraftment with sitagliptin in patients with multiple myeloma receiving autologous transplantation bad-data
Ongoing 2008-006266-29 Optimal Strategy for Coronary Artery Reperfusion not-yet-due
Ongoing 2008-006666-28 Myocardial Dyssynchrony and Sympathetic activity by cardiac gated-SPECT in patients with heart failure treated with cardiac resynchronyzation not-yet-due
Ongoing 2008-008722-73 ROLE OF PAROXETINE AS ADD-ON THERAPY TO GNRH AGONIST IN THE TREATMENT OF ENDOMETRIOSIS-RELATED CHRONIC PELVIC PAIN not-yet-due
Completed, but no date 2009-010060-41 Evaluation of efficacy of lithium salts therapy in patients with Amyotrophic Lateral Sclerosis. bad-data
Completed, but no date 2009-010861-21 Evaluation of the bilo-enteric anastomoses with contrast-enhanced MR-cholangiopancreatography (MRCP) with PRIMOVIST (Gd-EOB-DTPA-enhanced MRCP): comparison with conventional T2-weighted MRCP. bad-data
Completed, but no date Terminated 2009-011174-15 PRE-OPERATIVE CHEMO-RADIOTHERAPIC TREATMENT IN ESOPHAGEAL AND GASTRO-ESOPHAGEAL JUNCTION ADENOCARCINOMA bad-data
Ongoing 2009-012583-13 Phase II study of interleukin-2 and zoledronic acid as maintenance therapy in patients with multiple myeloma having undergone autograft not-yet-due
Ongoing 2009-015723-90 VARIATION OF PARATHYROID GLAND FOLLOWING CINACALCET USE IN DIALISYS PATIENTS WITH SONOGRAPHIC EVIDENCE OF SECONDARY HYPERPLASIA not-yet-due
Ongoing 2009-016737-95 ROSuvastatin Pretreatment to Reduce Embolization during Carotid Artery Stenting not-yet-due
Completed, but no date 2009-016738-28 Phase IV prospective, randomized, open with blind endpoints, parallel group study to evaluate the effect of Aliskiren on endothelial dysfunction in patients with essential hypertension bad-data
Ongoing 2011-001509-28 Efficacy and mechanisms of a short course of intensified insulin treatment on remission or responsiveness to oral therapy in type 2 diabetes not-yet-due
Ongoing 2011-003335-63 Effects of liraglutide on β-cell function in type 2 diabetic patients with secondary failure to oral hypoglycemic agents. A randomized, controlled, parallel groups, open-label, phase II study. not-yet-due
Ongoing 2013-001188-22 Interleukin 2 and zolendronic acid as maintaining treatment in multiple myeloma patients after autologous bone marrow transplant not-yet-due
Ongoing 2013-003080-59 PHASE III ITALIAN MULTICENTER STUDY COMPARING THE COMBINATION OF 5-FLUOROURACIL/FOLINIC ACID, OXALIPLATIN AND IRINOTECAN (FOLFOXIRI) VERSUS GEMCITABINE AS ADJUVANT TREATMENT FOR RESECTED PANCREATIC CA... not-yet-due
Ongoing 2014-004499-47 A case control, phase II, monocentric, randomized study, utilizing Zinc as enhancer of immune recovery and immune reconstitution in auto-transplant for multiple myeloma not-yet-due
Ongoing 2014-004592-23 Phase IV randomized, double blind, placebo-controlled study: role of hypovitaminosis D in heart failure and possible advantages of cholecalciferol (Vit D) administration not-yet-due
Ongoing 2015-004164-11 Effect of dapagliflozin on flow-mediated dilation and blood pressure (DAPA-BP): a phase III, randomized, open-label, parallel group study in hypertensive patients with controlled type 2 diabetes not-yet-due
Completed, but no date Terminated 2016-000742-61 CLINICAL STUDY OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN SUBJECTS WITH UNRESECTABLE OR METASTATIC MELANOMA. (NIVOLUMABIPILIMUMAB AT 1MG/KG – NIVOIPI01) bad-data